Toshiro Niki

Summary

Publications

  1. ncbi Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation
    Toshiro Niki
    Research Division, GalPharma Company, Ltd, FROM Kagawa, 2217 16 Hayashi cho, Takamatsu, Kagawa 761 0301, Japan
    J Biol Chem 284:32344-52. 2009
  2. ncbi A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity
    Karl Ziegelbauer
    Bayer Yakuhin, Ltd, Research Center Kyoto, Kyoto, Japan
    Br J Pharmacol 145:178-92. 2005

Detail Information

Publications2

  1. ncbi Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation
    Toshiro Niki
    Research Division, GalPharma Company, Ltd, FROM Kagawa, 2217 16 Hayashi cho, Takamatsu, Kagawa 761 0301, Japan
    J Biol Chem 284:32344-52. 2009
    ..Collectively, these findings shed light on a novel function of Gal-9 in mast cells and suggest a beneficial utility of Gal-9 for the treatment of allergic disorders including asthma...
  2. ncbi A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity
    Karl Ziegelbauer
    Bayer Yakuhin, Ltd, Research Center Kyoto, Kyoto, Japan
    Br J Pharmacol 145:178-92. 2005
    ..10 These data suggest that IKK-beta inhibitors offer an effective therapeutic approach for inhibiting chronic pulmonary inflammation...